Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
CURE

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...
News Medical on MSN

Oxybutynin shows promise in managing hot flashes for prostate cancer patients

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Pharmabiz

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...
GlobalData on MSN

CHMP grants positive opinion for J&J’s Akeega use

The CHMP decision is based on Phase III AMPLITUDE study results in 696 mHSPC patients.

Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide ...

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...
Campaign Live

Novartis’ Super Bowl ad encourages men to unclench their tight ends over prostate screenings

Legendary tight ends Rob Gronkowski, Tony Gonzalez, George Kittle and more star in the “Relax, it’s a blood test” initiative.